High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies

Journal of Infectious Diseases

Volumn 200, Issue 7, 2009, Pages 1119-1125

  Sharp, Colin P ^a   Lail, Alice ^d   Donfield, Sharyne ^d   Simmons, Ruth ^c   Leen, Clifford ^b   Klenerman, Paul ^c   Delwart, Eric ^e   Gomperts, Edward D ^f   Simmonds, Peter ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d University of California ^*  (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; IMMUNOGLOBULIN G; PROTEIN VP1; PROTEIN VP2;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PARV4; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SEROPREVALENCE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CAPSID PROTEINS; CHILD; CLONING, MOLECULAR; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HEMOPHILIA A; HUMANS; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; RISK FACTORS; SEROLOGIC TESTS; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL PROTEINS; YOUNG ADULT;

EID: 70349342725     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/605646     Document Type: Article

References (27)

1. Jones MS, Kapoor A, Lukashov W, Simmonds P, Hecht F, Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J Virol 2005;79:8230-8236 (Pubitemid 40853526)
2. Fryer TF, Kapoor A, Minor PD, Delwart E, Baylis SA. Novel parvovirus and related variant in human plasma. Emerg Infect Dis 2006; 12:151-154 (Pubitemid 43143554)
3. Fryer JF, Lucas SB, Padley D, Baylis SA. Parvoviruses PARV4/5 in hepatitis C virus-infected patient. Emerg Infect Dis 2007;13:175-176 (Pubitemid 46057865)
4. Lurcharchaiwong W, Chieochansin T, Payungpom S, Theamboonlers A, Poovorawan Y. Parvovirus 4 (PARV4) in serum of intravenous drug users and blood donors. Infection 2008;36:488-491
5. Söderlund-Venermo M., Hokynar K, Nieminen J, Rautakorpi H, Hedman K. Persistence of'human parvovirus B.19 in human tissues. Pathol Biol (Paris) 2002;50:307-316 (Pubitemid 34680092)
6. Norja P, Hokynař K, Aaltonen LM, et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A 2006; 103:7450-7453 (Pubitemid 43727853)
7. + T cells after acute B19 infection. PLoS Med 2005; 2:e343.
8. Manning A, Willey, SJ, Bell JE, Simmonds P. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis 2007;195:1345-1352 (Pubitemid 46649622)
9. Simmonds P, Manning A, Kenneil R, Carnie FW, Bell JE. Parenteral transmission of the novel human parvovirus, PARV4. Emerg Infect Dis 2007;13:1386-1388
10. Hilgartner MW, Donfield SM, Willoughby A, et al. Hemophilia growth and development study: design, methods, and entry data. Am J Pediatr Hematol Oncol 1993;15:208-18.
11. Heegaard ED, Qvortrup K, Christensen J. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19. J Med Virol 2002;66:246-252
12. Brown CS, Van Lent JW, Vlak JM, Spaan WJ. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins. J Virol 1991;65:2702-2706
13. Kantola K, Hedman L, Allander T et al. Serodiagnosis of'human bocavirus infection. Clin Infect Dis 2008;46:540-546
14. Lin F, Guan W, Cheng F, Yang N, Pintei D, Qiu J. ELISAs using human bocavirus VP2 virus-like particles for detection of antibodies against HBoV. J Virol Methods 2008; 149:110-117
15. Kahn JS, Kesebir D, Cotmore SF, et al. Seroepidemiology of human bocavirus defined using recombinant virus-like particles. J Infect Dis 2008; 198:41-50. (Pubitemid 351920288)
16. Endo R, Ishiguro N, Kikuta H, et al. Seroepidemiology of human bocavirus in Hokkaido prefecture, Japan. J Clin Microbiol 2007; 45: 3218-3223 (Pubitemid 47585642)
17. Mossong J, Hens N, Friederichs V et al. Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect 2008;136:1059-1068 (Pubitemid 351982926)
18. Gilbert NL, Gyorkos TW, Béliveau C, Rahme E, Muecke C, Soto JC. Seroprevalence of parvovirus B19 infection in daycare educators. Epidemiol Infect 2005;133:299-304. (Pubitemid 40439310)
19. Rohrer C, Gartner B, Sauerbrei A, et al. Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect 2008;136:1564-1575
20. Vyse AJ, Andrews NJ, Hesketh LM, Pebody R. The burden of parvovirus B19 infection in women of childbearing age in England and Wales. Epidemiol Infect 2007; 135:1345-1362 (Pubitemid 351148097)
21. Fryer JF, Hubbard AR, Baylis SA. Human parvovirus PARV4 in clotting factor VIII concentrates. Vox Sang 2007;93:341-347
22. Schneider B, Fryer JF, Oldenburg J, Brackmann HH, Baylis SA, EisHübinger AM. Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4. Haemophilia 2008; 14: 978-986
23. Blüme.1 J, Schmidt I, Effenberger W, et al. Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion 2002; 42: 1473-1481
24. Schwarz TF, Serke S, von Brunn A, et al. Heat stability of parvovirus B19: kinetics of inactivation. Zentralbl Bakteriol 1992;277:219-223
25. Brown KE, Simmonds P. Parvoviruses and blood transfusion. Transfusion 2007;47:1745-1750
26. Modrof J, Berting A, Tille B, et al. Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins. Transfusion 2008; 48:178-186
27. Simmonds P, Douglas J, Bestetti G, et al. A. third genotype of the human parvovirus PARV4 in sub-Saharan Africa. J Gen Virol 2008; 89: 2299-2302